August , September , OPTOBER ,PAA, page-3

Management will want to now demonstrate their Commercial acumen to bring the Options above the necessary strike price.

Baulko , you don't presume that the PAA BOD have a strategy to bring the Options into the money?

You could email the BOD like many of us have to encourage them to place their Commercial Business abilities on show,, because the BOD are now the only individuals that can demonstrate that PAA is well worth INVESTING in for a RETURN $$$..

Many other Biotechs increase in value on the way to commercialisation ,, as Positive Data is delivered (as it has been) Venture Risk is reduced..and that has value.. Capitalising on progress is Biotechs bread and Butter,,,NZT